Challenged to maintain revenue growth over the next five years, large pharmaceutical companies increasingly will partner with biotech firms to improve clinical development and R&D productivity, according to a panel of industry leaders convened by the Tufts Center for the Study of Drug Development. >>> Discuss This Story
